Sunati Sahoo, M.D.

• Neoadjuvant Systemic Therapy in Breast carcinoma
• Prognostic and Predictive Markers of Breast Carcinoma
• Quality and Outcome studies in the management of breast disease

 Featured Publications

Metabolic diversity within breast cancer brain-tropic cells determines metastatic fitness.

Parida PK, Marquez-Palencia M, Nair V, Kaushik AK, Kim K, Sudderth J, Quesada-Diaz E, Cajigas A, Vemireddy V, Gonzalez-Ericsson PI, Sanders ME, Mobley BC, Huffman K, Sahoo S, Alluri P, Lewis C, Peng Y, Bachoo RM, Arteaga CL, Hanker AB, DeBerardinis RJ, Malladi S, Cell Metab 2022 Jan 34 1 90-105.e7

Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer: a multicentre pooled analysis of 5161 patients.

Yau C, Osdoit M, van der Noordaa M, Shad S, Wei J, de Croze D, Hamy AS, Laé M, Reyal F, Sonke GS, Steenbruggen TG, van Seijen M, Wesseling J, Martín M, Del Monte-Millán M, López-Tarruella S, Boughey JC, Goetz MP, Hoskin T, Gould R, Valero V, Edge SB, Abraham JE, Bartlett JMS, Caldas C, Dunn J, Earl H, Hayward L, Hiller L, Provenzano E, Sammut SJ, Thomas JS, Cameron D, Graham A, Hall P, Mackintosh L, Fan F, Godwin AK, Schwensen K, Sharma P, DeMichele AM, Cole K, Pusztai L, Kim MO, van 't Veer LJ, Esserman LJ, Symmans WF, Lancet Oncol 2022 Jan 23 1 149-160

Assessment of Residual Cancer Burden and Event-Free Survival in Neoadjuvant Treatment for High-risk Breast Cancer: An Analysis of Data From the I-SPY2 Randomized Clinical Trial.

Symmans WF, Yau C, Chen YY, Balassanian R, Klein ME, Pusztai L, Nanda R, Parker BA, Datnow B, Krings G, Wei S, Feldman MD, Duan X, Chen B, Sattar H, Khazai L, Zeck JC, Sams S, Mhawech-Fauceglia P, Rendi M, Sahoo S, Ocal IT, Fan F, LeBeau LG, Vinh T, Troxell ML, Chien AJ, Wallace AM, Forero-Torres A, Ellis E, Albain KS, Murthy RK, Boughey JC, Liu MC, Haley BB, Elias AD, Clark AS, Kemmer K, Isaacs C, Lang JE, Han HS, Edmiston K, Viscusi RK, Northfelt DW, Khan QJ, Leyland-Jones B, Venters SJ, Shad S, Matthews JB, Asare SM, Buxton M, Asare AL, Rugo HS, Schwab RB, Helsten T, Hylton NM, van 't Veer L, Perlmutter J, DeMichele AM, Yee D, Berry DA, Esserman LJ, JAMA Oncol 2021 Sep

A Phase I/Ib Trial of PD 0332991 (Palbociclib) and T-DM1 in HER2-Positive Advanced Breast Cancer After Trastuzumab and Taxane Therapy.

Haley B, Batra K, Sahoo S, Froehlich T, Klemow D, Unni N, Ahn C, Rodriguez M, Hullings M, Frankel AE, Clin Breast Cancer 2021 Mar

Association of Event-Free and Distant Recurrence-Free Survival With Individual-Level Pathologic Complete Response in Neoadjuvant Treatment of Stages 2 and 3 Breast Cancer: Three-Year Follow-up Analysis for the I-SPY2 Adaptively Randomized Clinical Trial.

Yee D, DeMichele AM, Yau C, Isaacs C, Symmans WF, Albain KS, Chen YY, Krings G, Wei S, Harada S, Datnow B, Fadare O, Klein M, Pambuccian S, Chen B, Adamson K, Sams S, Mhawech-Fauceglia P, Magliocco A, Feldman M, Rendi M, Sattar H, Zeck J, Ocal IT, Tawfik O, LeBeau LG, Sahoo S, Vinh T, Chien AJ, Forero-Torres A, Stringer-Reasor E, Wallace AM, Pusztai L, Boughey JC, Ellis ED, Elias AD, Lu J, Lang JE, Han HS, Clark AS, Nanda R, Northfelt DW, Khan QJ, Viscusi RK, Euhus DM, Edmiston KK, Chui SY, Kemmer K, Park JW, Liu MC, Olopade O, Leyland-Jones B, Tripathy D, Moulder SL, Rugo HS, Schwab R, Lo S, Helsten T, Beckwith H, Haugen P, Hylton NM, Van't Veer LJ, Perlmutter J, Melisko ME, Wilson A, Peterson G, Asare AL, Buxton MB, Paoloni M, Clennell JL, Hirst GL, Singhrao R, Steeg K, Matthews JB, Asare SM, Sanil A, Berry SM, Esserman LJ, Berry DA, JAMA Oncol 2020 09 6 9 1355-1362

Comparison of Dako HercepTest and Ventana PATHWAY Anti-HER2 (4B5) Tests and Their Correlation With Fluorescent In Situ Hybridization in Breast Carcinoma.

Lucas E, Jabbar SB, Molberg K, Fang Y, Xie XJ, Blacketer S, Sahoo S, Appl Immunohistochem Mol Morphol 2019 07 27 6 403-409

Combined Targeting of Estrogen Receptor Alpha and XPO1 Prevent Akt Activation, Remodel Metabolic Pathways and Induce Autophagy to Overcome Tamoxifen Resistance.

Kulkoyluoglu-Cotul E, Smith BP, Wrobel K, Zhao YC, Chen KLA, Hieronymi K, Imir OB, Duong K, O'Callaghan C, Mehta A, Sahoo S, Haley B, Chang H, Landesman Y, Madak-Erdogan Z, Cancers (Basel) 2019 Apr 11 4

Isolated Contralateral Axillary Lymph Node Involvement in Breast Cancer Represents a Locally Advanced Disease Not Distant Metastases.

Chkheidze R, Sanders MAG, Haley B, Leitch AM, Sahoo S Clin. Breast Cancer 2017 Nov

Pathologic Findings of Breast Lesions Detected on Magnetic Resonance Imaging.

Jabbar SB, Lynch B, Seiler S, Hwang H, Sahoo S Arch. Pathol. Lab. Med. 2017 Aug

Pathology Considerations in Patients Treated with Neoadjuvant Chemotherapy.

Sahoo S, Lester SC Surg Pathol Clin 2012 Sep 5 3 749-74

 Featured Books

1. Chapter 54. Interpreting Breast Pathology in the Setting of Neoadjuvant Chemotherapy. In Breast Surgical Techniques and Interdisciplinary Management

Sahoo S, and Lester SC (2011). New York, NY, Springer

2. Chapter 28. Pathology of Therapeutic Response after Neoadjuvant Therapy in Breast Cancer. In Breast Pathology

Sahoo S, David Dabbs, Rohit Bhargava (2012). Philadelphia, PA, Elsevier

4. Pathological considerations in patients treated with neoadjuvant chemotherapy. In Breast Pathology: Diagnosis and Insights in Surgical pathology clinics

Sahoo S, and Lester SC (2012). Philadelphia, PA, Saunders

6. Chapter 10. Mimickers of Lung carcinoma in cytology and small biopsy material. In Diagnosing Lung Carcinoma on Small Biopsies and Cytology

E Lucas, and Sahoo S. (2015). New York, NY, Springer

7. Chapter 10. Invasive ductal carcinoma including microinvasive carcinoma, tubular carcinoma and cribriform carcinoma. In A Comprehensive Guide to Needle Core Biopsies of the Breast

Saluja K. Hwang H, Sahoo S. (2014). New York, NY, Springer

8. Chapter 14. Neoplasia: Atypical lobular hyperplasia and lobular carcinoma in situ. In A Comprehensive Guide to Needle Core Biopsies of the Breast

Hwang H, Sahoo S (2016). New York, NY, Springer

9. Chapter15. Invasive lobular carcinoma. In A Comprehensive Guide to Needle Core Biopsies of the Breast

Hwang H, Sahoo S (2016). New York, NY, Springer

10. Chapter 28. Pathology of Therapeutic Response after Neoadjuvant Therapy in Breast Cancer. In Breast Pathology, 2nd ed.

Sahoo S, David Dabbs, Rohit Bhargava: (2016). Philadelphia, PA, Elsevier

11. Chapter 29. Special Types of breast Carcinoma: Tubular Carcinoma, Mucinous Carcinoma, Cribriform Carcinoma, Invasive Micropapillary Carcinoma, Medullary Carcinoma. In Breast Pathology, 2nd ed

Sahoo S, Shin S (2016). Philadelphia, PA, Elsevier

3. Chapter 29. Special Types of breast Carcinoma: Tubular Carcinoma, Mucinous Carcinoma, Cribriform Carcinoma, Invasive Micropapillary Carcinoma, Medullary Carcinoma in Dabbs (ed). In Breast Pathology

Sahoo S, Shin S (2012). Philadelphia, PA, Elsevier

5. Chapter 56. Assessment of Treatment Response After Neoadjuvant Therapy. In Diseases of the Breast, Chapter 56, 5th edition

Sahoo S, and Lester SC: (2014). Philadelphia, PA, Wolters Kluwer Health

• Leaders in Clinical Excellence: Mentoring Award
  UTSW Medical Center (2021)
• Best Platform presentation at the Annual Texas Society of Pathology, San Antonio, TX (given to the pathology resident)
  UTSW Medical Center, TX (2015)
• Golden Apple Award for Outstanding Faculty Teacher in Pathology
  University of Louisville, KY (2010-2011)
• Service Award in recognition of service and contribution to pathology as the interim director of Anatomic Pathology
  University of Louisville, KY (2009-2010)
• Golden Apple Award for Outstanding Faculty Teacher in Pathology
  University of Louisville, KY (2005-2006)
• Sheard Sanford Award for best platform presentation given to the resident
  American Society of Clinical Pathologists (2004)
• Robert Preist Fellowship Award Grant
  University of Chicago, IL (2002)

• College of American Pathologists
• United States and Canadian Academy of Pathology